Luca Maini
@lucamaini.bsky.social
150 followers 340 following 11 posts
Assistant Professor of Health Care Policy at @HMSHCP. I study competition and regulation in pharmaceutical markets.
Posts Media Videos Starter Packs
lucamaini.bsky.social
I'm going to put "Is ciccio _||_ age an assumption?" on a t-shirt
lucamaini.bsky.social
Postdoc alert! The deadline for the position at @hmshcp.bsky.social is in a little over two weeks. If you are on the econ/health policy market and are interested in pharma, please consider applying! www.aeaweb.org/joe/listing....
American Economic Association: JOE Listings - February 1, 2025 - July 31, 2025
www.aeaweb.org
lucamaini.bsky.social
I have terrible news. I took a sneak peek at current submission numbers for ASHEcon and the Prescription Drugs area is not number one. We're not even on the podium. Are we gonna let Health Systems and Health Care Financing win?
ashecon.bsky.social
🔥 Deadline extended: Dec. 18, 2024 at 11:59 PM PST

Submit your abstracts for the 14th ASHEcon Conference 👉 ashecon.org/announcement...

The conference will be held June 22-25, 2025 at the Grand Hyatt Nashville in Nashville, TN. We hope to see you there!
lucamaini.bsky.social
I'm the chair of the prescription drug area this year. Please send in all your pharma papers! The more submissions an area receives, the more we accept. If you need help putting together a session, check the single abstract listing (link at ashecon.org/2025-nashvil...) or email me!
lucamaini.bsky.social
Third takeaway: most other acquisitions seem to have no obvious effect on prices or coverage (caveat: drug prices move a lot, so it’s hard to detect these effects with precision)
lucamaini.bsky.social
Second takeaway: acquisitions that are not disclosed to the FTC are followed by massive increases in price, and large declines in formulary coverage (caveat: there are not that many of them!)
lucamaini.bsky.social
First takeaway: there is a lot of M&A! One third of all branded drugs are acquired prior to patent expiration. Most of them are acquired by companies that have NO other drug with a similar indication.
lucamaini.bsky.social
Research update: we have a new version of our pharma M&A paper! AND, we posted the data we collected on m&a deals. Links below, main takeaways in thread.
Paper summary: lucamaini.com/working-pape...
Full draft: lucamaini.com/s/feng_hwang...
Data: www.lucamaini.com/data
lucamaini.bsky.social
I have a few overdue research updates I will post about in the next week or two. But first, our department is hiring a postdoc to work with me on pharma topics. Posting here: benny.aeaweb.org/joe/listing....
Please circulate, and feel free to reach out with any questions!
American Economic Association: JOE Listings - August 1, 2024 - January 31, 2025
benny.aeaweb.org
lucamaini.bsky.social
For a small fee, I will send a dramatic reading in a heavy Italian accent
lucamaini.bsky.social
Is it weird that the FTC complaint against PBMs is the most riveting evening read I have done in years? www.ftc.gov/system/files...
www.ftc.gov